Loading...
Targeting the KRAS Pathway in Non-Small Cell Lung Cancer
Lung cancer remains the leading cause of cancer-related deaths worldwide. However, significant progress has been made individualizing therapy based on molecular aberrations (e.g., EGFR, ALK) and pathologic subtype. KRAS is one of the most frequently mutated genes in non-small cell lung cancer (NSCLC...
Na minha lista:
| Udgivet i: | Oncologist |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AlphaMed Press
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5153335/ https://ncbi.nlm.nih.gov/pubmed/27807303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0084 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|